世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

患者エンゲージメントソリューション市場:コンポーネント別(ソフトウェア、サービス)、デリバリー別(オンプレミス、クラウド)、治療領域別(CVD、糖尿病、肥満、フィットネス)、機能別(電子処方、バーチャルケア)、エンドユーザー別(プロバイダー、支払者、患者)、地域別市場展望 2030年までの世界予測


Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) & Regional Outlook Global Forecast up to 2030

この患者管理ソリューション市場の技術的、財務的、市場指向の分析のためのデータを見つけ、収集するために、この市場調査研究では、二次情報源、ディレクトリ、データベースをかなり利用しました。重要な質的・... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
IHR Insights
アイエイチアールインサイト
2023年11月14日 US$4,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
110 英語

 

サマリー

この患者管理ソリューション市場の技術的、財務的、市場指向の分析のためのデータを見つけ、収集するために、この市場調査研究では、二次情報源、ディレクトリ、データベースをかなり利用しました。重要な質的・量的データを収集・検証し、市場の将来性を評価するため、重要な業界プレーヤー、主題専門家(SME)、重要な市場プレーヤーのCレベル幹部、業界コンサルタントなどの専門家を含む、さまざまな主要回答者との詳細なインタビューを実施しました。最終的な市場規模を把握するため、様々な二次調査手法を用いて市場規模を評価し、一次調査からのインプットと三角測量した。
本調査の二次情報源には、WHO、ATA、AHA、AAHMなどの政府機関の出版物が含まれる。プレスリリース、業界団体、ビジネス団体、専門家団体、ビジネス出版物や研究誌、企業や規制当局の提出書類(年次報告書、SEC提出書類、投資家向けプレゼンテーション、財務諸表など)、その他の情報源は二次情報源の一例である。世界市場の総規模は、二次データの収集と分析によって推定され、この推定値は一次調査によって確認されました。
コンポーネント別の患者管理ソリューション市場
- ハードウェア
- ソフトウェア
- スタンドアロンソフトウェア
- 統合ソフトウェア
- サービス
配信モードに基づく患者参加型ソリューション市場
- 前提モード
- クラウドベース・モード
患者管理ソリューション市場:アプリケーション別
- 健康管理
- 在宅医療管理
- ソーシャル
- 財務健康管理
治療分野に基づく患者エンゲージメントソリューション市場
- 慢性疾患
- 心血管疾患(CVD)
- 糖尿病
- 肥満
- その他の慢性疾患
- 女性の健康
- フィットネス
- その他の治療分野
機能別の患者管理ソリューション市場
- はじめに
- 電子処方箋
- バーチャル診察
- 患者/顧客のスケジューリング
- 文書管理
エンドユーザーに基づく患者管理ソリューション市場
- プロバイダー
- 支払者
- 患者
- その他のエンドユーザー
患者管理ソリューション市場:地域別
- 北米
o 米国
カナダ
- ヨーロッパ
o ドイツ
o イギリス
o フランス
o イタリア
o スペイン
o 残りのヨーロッパ(RoE)
- アジア太平洋(APAC)
o 中国
o 日本
o インド
o オーストラリア
o 韓国
o その他のアジア太平洋地域(RoAPAC)
- ラテンアメリカ(LATAM)
o ブラジル
o アルゼンチン
o その他の南米諸国
- 中東・アフリカ(MEA)
o アラブ首長国連邦
o トルコ
o サウジアラビア
o 南アフリカ
o その他の中東・アフリカ
2022年の市場は、ウェブとクラウドベースのセグメントが優勢であった。これらのソリューションの人気が高まっているのは、統合された機能、使いやすさ、最小限の処理コスト、データバックアップの容易さ、リアルタイムのデータ追跡へのリモートアクセスなどに起因している。上記の理由から、企業はウェブおよびクラウドベースの患者エンゲージメント・ソリューションに投資している。
例えば、マイクロソフトは2020年5月、同社初の業界特化型クラウドであるMicrosoft Cloud for Healthcareを発表した。遠隔医療やデータ分析などの機能を備えたこのプラットフォームは、医師が患者との関わりを改善し、医療チーム全体の連携を高めることを目的としている。患者データのセキュリティ、検索の利便性、アクセシビリティは、オンプレミスのサービスによって提供される。オンプレミス型サービスが好まれるのは、そのほとんどが施設内でデータにフルアクセスできるからである。
2022年に最も大きなシェアを占めたセグメントは、ソフトウェアとハードウェアであり、予測期間中の年平均成長率は約17%と最も速くなると予想される。このソリューションの主要コンポーネントは、患者エンゲージメントのためのハードウェアとソフトウェアである。ユーザーフレンドリーなインターフェースと継続的な製品アップデートにより、インストール、利用、記録の取得が容易である。オールスクリプツの人気のあるモバイルファーストのカスタマイズされた企業向け患者エンゲージメントツールは、FollowMyHealthと呼ばれている。医療提供者、病院、医療システムは、患者の幸福度を向上させ、治療の質を促進するためにこれを使用しています。
コミュニケーションはあらゆる患者エンゲージメント・ソリューションの基盤であるため、2022年の売上シェアは35.0%以上と最も高い。この大部分は、mhealth、遠隔医療、およびテキスト、ビデオ、音声を介した追加の仮想通信オプションの要件と受け入れの急増に起因する。この流行は、すでに急速に普及していた仮想通信システムの普及を加速させ、メンタルヘルス、遠隔患者モニタリング、その他多くのモダリティへの適用性を高めている。
2022年の収益シェアは40.0%を超え、慢性疾患管理が市場を牽引した。このセグメントの高いシェアは、重要な市場における高齢化、慢性疾患の頻度、COVID-19パンデミックによるデジタル技術の採用など、いくつかの要因の結果である。患者エンゲージメント・ソリューションは、病状の回避や特定を容易にし、医療提供者とともに、あるいは自分自身で管理することで、慢性疾患の管理を支援する。
2022年には、外来患者健康管理分野が市場収益の約35.0%を占め、支配的なセグメントとなった。予測期間中、その他のアプリケーション・セグメントを構成する研究開発・予防医療アプリケーション分野は、17.0%と最も速いペースで成長すると予想される。慢性疾患と診断された患者は、継続的なケアと状態の管理方法に関する教育を必要とする。医療消費者主義の高まりにより、患者はケアの計画、モニタリング、最適化に積極的に関与するようになっている。
2022年には、医療提供者の売上シェアが最も高くなり、45.0%を超えた。最も多くの患者を治療することに加え、医療提供者は、一般的な医療問題から専門的な医療問題まで、何でも相談できる第一選択者である。したがって、患者エンゲージメント・システムの最大のユーザーは、こうしたエンドユーザーである。米国のノースウェル・ヘルスは2021年12月、HIPAAのセキュリティ規制を守りつつモビリティを促進し、ポイントオブケアの医療データを交換するため、一部の臨床施設にプレイバック・ヘルスの患者エンゲージメント・プラットフォームを導入した。
患者エンゲージメント・ソリューション市場で事業を展開する主要企業には、IBM(米国)、McKesson Corporation(米国)、Allscripts(米国)、Cerner Corporation(米国)、Epic Systems Corporation(米国)、Orion Health(ニュージーランド)、GetWellNetwork(米国)、athenahealth(米国)、Oneview Healthcare(アイルランド)、MEDITECH(米国)、IQVIA(米国)などがある、Get Real Health(米国)、Cognizant(米国)、Symphony Care(米国)、Harris Healthcare(米国)、Kareo(米国)、CureMD Healthcare(米国)、eClinicalWorks(米国)、Lincor Solutions(米国)、AdvancedMD(米国)、WellStack(米国)、IQVIA(米国)、Vivify Health(米国)、Medhost(米国)、Validic(米国)MEDISYSINC(米国)、Patient point LLC(米国)。
- 本レポートは、患者管理ソリューション市場の最も重要な属性を示しており、これが市場を牽引し、機会を提供しています。
- この調査レポートは、患者管理ソリューション市場の成長を市場のいくつかのセグメントに基づいて詳細に分析します。
- 患者管理ソリューション市場の過去と現在の動向予測を提示します。
- また、患者関与ソリューション市場の主要企業の主要戦略や能力などの競争分析も提示しています。

ページTOPに戻る


目次

Table of Contents
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Component: Market Size & Analysis
5.1. Overview
5.2. Hardware
5.3. Software
5.4. Standalone Software
5.5. Integrated Software
5.6. Services
6. Delivery mode: Market Size & Analysis
6.1. Overview
6.2. PREMISE Mode
6.3. CLOUD-BASED Mode
7. Application: Market Size & Analysis
7.1. Overview
7.2. Health management
7.3. Home health management
7.4. Social
7.5. Financial health management
8. Therapeutic Area: Market Size & Analysis
8.1. Overview
8.2. Chronic diseases
8.3. Cardiovascular diseases (CVD)
8.4. Diabetes
8.5. Obesity
8.6. Other chronic diseases
8.7. Women’s health
8.8. Fitness
8.9. Other Therapeutic Areas
9. Functionality: Market Size & Analysis
9.1. Overview
9.2. Chronic diseases
9.3. Cardiovascular diseases (CVD)
9.4. Diabetes
9.5. Obesity
9.6. Other chronic diseases
9.7. Women’s health
9.8. Fitness
9.9. Other Therapeutic Areas
10. End User: Market Size & Analysis
10.1. Overview
10.2. Chronic diseases
10.3. Cardiovascular diseases (CVD)
10.4. Diabetes
10.5. Obesity
10.6. Other chronic diseases
10.7. Women’s health
10.8. Fitness
10.9. Other Therapeutic Areas
11. Geography: Market Size & Analysis
11.1. Overview
11.2. North America (U.S., Mexico, Canada)
11.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
11.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
11.5. Latin America (Brazil, Argentina)
11.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
12. Competitive Landscape
12.1. Competitor Comparison Analysis
12.2. Market Developments
12.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
12.2.2. Product Launches and execution
13. Vendor Profiles
13.1. Allscripts Healthcare, LLC
13.1.1. Overview
13.1.2. Financial Overview
13.1.3. Product Offerings
13.1.4. Developments
13.1.5. Business Strategy
13.2. Orion Health
13.2.1. Overview
13.2.2. Financial Overview
13.2.3. Product Offerings
13.2.4. Developments
13.2.5. Business Strategy
13.3. Cerner Corporation
13.3.1. Overview
13.3.2. Financial Overview
13.3.3. Product Offerings
13.3.4. Developments
13.3.5. Business Strategy
13.4. Athenahealth, Inc.
13.4.1. Overview
13.4.2. Financial Overview
13.4.3. Product Offerings
13.4.4. Developments
13.4.5. Business Strategy
13.5. McKesson Corporation
13.5.1. Overview
13.5.2. Financial Overview
13.5.3. Product Offerings
13.5.4. Developments
13.5.5. Business Strategy
13.6. IBM
13.6.1. Overview
13.6.2. Financial Overview
13.6.3. Product Offerings
13.6.4. Developments
13.6.5. Business Strategy
13.7. Medecision
13.7.1. Overview
13.7.2. Financial Overview
13.7.3. Product Offerings
13.7.4. Developments
13.7.5. Business Strategy
13.8. GetWellNetwork, Inc.
13.8.1. Overview
13.8.2. Financial Overview
13.8.3. Product Offerings
13.8.4. Developments
13.8.5. Business Strategy
13.9. MEDHOST
13.9.1. Overview
13.9.2. Financial Overview
13.9.3. Product Offerings
13.9.4. Developments
13.9.5. Business Strategy
13.10. Lincor
13.10.1. Overview
13.10.2. Financial Overview
13.10.3. Product Offerings
13.10.4. Developments
13.10.5. Business Strategy

14. Analyst Opinion
15. Annexure
15.1. Report Scope
15.2. Market Definitions
15.3. Research Methodology
15.3.1. Data Collation and In-house Estimation
15.3.2. Market Triangulation
15.3.3. Forecasting
15.4. Report Assumptions
15.5. Declarations
15.6. Stakeholders
15.7. Abbreviations

ページTOPに戻る



図表リスト

Tables
TABLE 1. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 2. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HARDWARE, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR STANDALONE SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR INTEGRATED SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 8. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PREMISE MODE, 2021-2030 (USD BILLION)
TABLE 9. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CLOUD-BASED MODE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 11. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HEALTH MANAGEMENT, 2021-2030 (USD BILLION)
TABLE 12. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HOME HEALTH MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 13. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SOCIAL, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 14. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR FINANCIAL HEALTH MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 15. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY THERAPEUTIC AREA, 2021-2030 (USD BILLION)
TABLE 16. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CHRONIC DISEASES, 2021-2030 (USD BILLION)
TABLE 17. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CARDIOVASCULAR DISEASES (CVD), BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 18. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR DIABETES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 19. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR OBESITY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 20. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CHRONIC DISEASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 21. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR WOMEN’S HEALTH, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 22. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR FITNESS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 23. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY FUNCTIONALITY, 2021-2030 (USD BILLION)
TABLE 24. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR INTRODUCTION, 2021-2030 (USD BILLION)
TABLE 25. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR E-PRESCRIBING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 26. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR VIRTUAL CONSULTATION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 27. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PATIENT/CLIENT SCHEDULING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 28. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR DOCUMENT MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 29. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 30. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PROVIDERS, 2021-2030 (USD BILLION)
TABLE 31. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PAYERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 32. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PATIENTS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 33. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR OTHER END USERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 34. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 35. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 36. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 37. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 38. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 39. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 40. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 41. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 42. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 43. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 44. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 46. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 47. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 48. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 49. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 50. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 51. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 52. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 53. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, END USE INDUSTRIES, 2021-2030 (USD BILLION)
TABLE 54. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 55. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 56. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 57. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 59. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 60. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 61. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 62. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 63. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 64. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 65. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 66. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 67. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 68. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 69. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 70. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 71. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 72. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 73. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 74. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 75. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 76. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 77. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 78. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 79. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 80. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 81. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 82. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 83. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 84. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 85. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 86. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 87. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 88. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 89. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 90. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 91. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 92. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 93. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 94. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 95. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 96. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 97. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 98. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 99. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 100. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 101. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 102. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 103. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 104. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 105. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 106. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 107. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 108. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 109. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 110. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 111. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 112. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 113. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 114. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 115. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 116. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 117. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 118. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 119. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 120. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 121. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 122. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 123. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 124. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 125. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 126. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 127. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 128. ALLSCRIPTS HEALTHCARE, LLC: FINANCIALS
TABLE 129. ALLSCRIPTS HEALTHCARE, LLC: PRODUCTS & SERVICES
TABLE 130. ALLSCRIPTS HEALTHCARE, LLC: RECENT DEVELOPMENTS
TABLE 131. ORION HEALTH: FINANCIALS
TABLE 132. ORION HEALTH: PRODUCTS & SERVICES
TABLE 133. ORION HEALTH: RECENT DEVELOPMENTS
TABLE 134. CERNER CORPORATION: FINANCIALS
TABLE 135. CERNER CORPORATION : PRODUCTS & SERVICES
TABLE 136. CERNER CORPORATION: RECENT DEVELOPMENTS
TABLE 137. MCKESSON CORPORATION: FINANCIALS
TABLE 138. MCKESSON CORPORATION: PRODUCTS & SERVICES
TABLE 139. MCKESSON CORPORATION: RECENT DEVELOPMENTS
TABLE 140. ATHENAHEALTH, INC.: FINANCIALS
TABLE 141. ATHENAHEALTH, INC.: PRODUCTS & SERVICES
TABLE 142. ATHENAHEALTH, INC.: RECENT DEVELOPMENTS
TABLE 143. IBM: FINANCIALS
TABLE 144. IBM: PRODUCTS & SERVICES
TABLE 145. IBM: RECENT DEVELOPMENTS
TABLE 146. MEDECISION: FINANCIALS
TABLE 147. MEDECISION: PRODUCTS & SERVICES
TABLE 148. MEDECISION: DEVELOPMENTS
TABLE 149. GETWELLNETWORK, INC.: FINANCIALS
TABLE 150. GETWELLNETWORK, INC.: PRODUCTS & SERVICES
TABLE 151. GETWELLNETWORK, INC.: RECENT DEVELOPMENTS
TABLE 152. MEDHOST: FINANCIALS
TABLE 153. MEDHOST: RODUCTS & SERVICES
TABLE 154. MEDHOST: RECENT DEVELOPMENTS
TABLE 155. LINCOR: FINANCIALS
TABLE 156. LINCOR: PRODUCTS & SERVICES
TABLE 157. LINCOR: RECENT DEVELOPMENTS

 

ページTOPに戻る


 

Summary

In order to find and gather data for this technical, financial, and market-oriented analysis of the Patient Engagement Solutions market, this market research study made considerable use of secondary sources, directories, and databases. To gather and validate crucial qualitative and quantitative data and evaluate market prospects, in-depth interviews were performed with a range of primary respondents, including important industry players, subject-matter experts (SMEs), C-level executives of significant market players, and industry consultants, among other experts. To get the final market size, the size of the market was evaluated using a variety of secondary research techniques and triangulated with inputs from primary research.
The research study's secondary sources include publications from government agencies like the WHO, ATA, AHA, and AAHM. Press releases; trade, business, and professional associations; business publications and research journals; corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); and other sources are examples of secondary sources. The total size of the global market was estimated by the collection and analysis of secondary data, and this estimate was confirmed by primary research.
Patient Engagement Solutions Market based on Component:
• Hardware
• Software
• Standalone Software
• Integrated Software
• Services
Patient Engagement Solutions Market based on Delivery Mode:
• PREMISE Mode
• CLOUD-BASED Mode
Patient Engagement Solutions Market based on Application:
• Health management
• Home health management
• Social
• Financial health management
Patient Engagement Solutions Market based on Therapeutic Area:
• Chronic diseases
• Cardiovascular diseases (CVD)
• Diabetes
• Obesity
• Other chronic diseases
• Women’s health
• Fitness
• Other Therapeutic Areas
Patient Engagement Solutions Market based on Functionality:
• Introduction
• E-Prescribing
• Virtual Consultation
• Patient/Client Scheduling
• Document Management
Patient Engagement Solutions Market based on End User:
• Providers
• Payers
• Patients
• Other End users
Patient Engagement Solutions Market based on Geography:
• North America
o US
o Canada
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe (RoE)
• Asia Pacific (APAC)
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
o Brazil
o Argentina
o Rest of South America
• Middle East and Africa (MEA)
o UAE
o Turkey
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
2022 saw a dominance of the web and cloud-based segments of the market. During the projected period, the segment is also expected to grow at the fastest rate.These solutions' growing popularity can be attributed to their integrated features, ease of use, minimal handling costs, ease of data backup, and remote access to real-time data tracking. Businesses are investing in web- and cloud-based patient engagement solutions for the reasons outlined above.
For example, Microsoft announced Microsoft Cloud for Healthcare in May 2020, the company's first industry-specific cloud. With capabilities like telemedicine and data analytics, the platform is meant to help doctors improve patient involvement and association across health teams. Patient data security, convenience of retrieval, and accessibility are offered by on-premise services. The preference for on-premise services stems mostly from having full access to the data on the premises.
The segment with the biggest share in 2022 was software and hardware, and during the course of the projection period, it is anticipated to grow at the quickest CAGR of roughly 17%. The solution's primary components are hardware and software for patient engagement. Due to its user-friendly interfaces and ongoing product updates, it is easy to install, utilise, and retrieve records. Popular mobile-first, customised, enterprise patient engagement tool from Allscripts is called FollowMyHealth. Providers, hospitals, and health systems use it to improve patient happiness and promote treatment quality.
Since communication is the foundation of any patient engagement solution, it has the highest revenue share (more than 35.0%) in 2022. The significant portion is ascribed to the upsurge in the requirement and acceptance of mhealth, telehealth, and additional virtual communication options through text, video, and voice. The epidemic has accelerated the already rapid uptake of virtual communication systems and increased their applicability to mental health, remote patient monitoring, and numerous other modalities.
With a revenue share of more than 40.0% in 2022, chronic disease management led the market. The high share of the segment is a result of several factors, including the ageing population in important markets, the frequency of chronic illnesses, and the COVID-19 pandemic-induced adoption of digital technologies. Patient engagement solutions assist in the management of chronic diseases by making it easier to avoid and identify the condition, as well as to manage it with a healthcare provider or on one's own.
In 2022, the outpatient health management sector accounted for about 35.0% of market revenue, making it the dominant segment. Over the course of the forecast period, the R&D and preventive care application sector, which comprises the others application segment, is expected to grow at the quickest pace of 17.0%. Individuals with chronic illness diagnoses require ongoing care and education about how to manage their condition. Patients are becoming more actively involved in the planning, monitoring, and optimisation of their care as a result of the growing healthcare consumerism.
In 2022, providers had the highest revenue share—more than 45.0%. In addition to treating the greatest number of patients, providers are the first choice for consultation on anything from general to specialised medical issues. Therefore, the biggest users of patient engagement systems are these end users. Northwell Health in the United States implemented a Playback Health patient engagement platform in December 2021 at a few of its clinical facilities to encourage mobility and exchange point-of-care medical data while upholding HIPAA security regulations.
Some of the key players operating in patient engagement solutions market are IBM (US), McKesson Corporation (US), Allscripts (US), Cerner Corporation (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Symphony Care (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), WellStack(US), IQVIA (US), Vivify Health (US), Medhost (US), Validic (US) MEDISYSINC (US), and Patient point LLC (US).
• This report illustrates the most vital attributes of the Patient Engagement Solutions Market, which are driving and providing opportunities.
• This research gives an in-depth analysis of the Patient Engagement Solutions Market growth on the basis of several segments in the market.
• This report presents the predictions of the past and present trends of the Patient Engagement Solutions Market.
• This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Patient Engagement Solutions Market.



ページTOPに戻る


Table of Contents

Table of Contents
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Component: Market Size & Analysis
5.1. Overview
5.2. Hardware
5.3. Software
5.4. Standalone Software
5.5. Integrated Software
5.6. Services
6. Delivery mode: Market Size & Analysis
6.1. Overview
6.2. PREMISE Mode
6.3. CLOUD-BASED Mode
7. Application: Market Size & Analysis
7.1. Overview
7.2. Health management
7.3. Home health management
7.4. Social
7.5. Financial health management
8. Therapeutic Area: Market Size & Analysis
8.1. Overview
8.2. Chronic diseases
8.3. Cardiovascular diseases (CVD)
8.4. Diabetes
8.5. Obesity
8.6. Other chronic diseases
8.7. Women’s health
8.8. Fitness
8.9. Other Therapeutic Areas
9. Functionality: Market Size & Analysis
9.1. Overview
9.2. Chronic diseases
9.3. Cardiovascular diseases (CVD)
9.4. Diabetes
9.5. Obesity
9.6. Other chronic diseases
9.7. Women’s health
9.8. Fitness
9.9. Other Therapeutic Areas
10. End User: Market Size & Analysis
10.1. Overview
10.2. Chronic diseases
10.3. Cardiovascular diseases (CVD)
10.4. Diabetes
10.5. Obesity
10.6. Other chronic diseases
10.7. Women’s health
10.8. Fitness
10.9. Other Therapeutic Areas
11. Geography: Market Size & Analysis
11.1. Overview
11.2. North America (U.S., Mexico, Canada)
11.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
11.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
11.5. Latin America (Brazil, Argentina)
11.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
12. Competitive Landscape
12.1. Competitor Comparison Analysis
12.2. Market Developments
12.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
12.2.2. Product Launches and execution
13. Vendor Profiles
13.1. Allscripts Healthcare, LLC
13.1.1. Overview
13.1.2. Financial Overview
13.1.3. Product Offerings
13.1.4. Developments
13.1.5. Business Strategy
13.2. Orion Health
13.2.1. Overview
13.2.2. Financial Overview
13.2.3. Product Offerings
13.2.4. Developments
13.2.5. Business Strategy
13.3. Cerner Corporation
13.3.1. Overview
13.3.2. Financial Overview
13.3.3. Product Offerings
13.3.4. Developments
13.3.5. Business Strategy
13.4. Athenahealth, Inc.
13.4.1. Overview
13.4.2. Financial Overview
13.4.3. Product Offerings
13.4.4. Developments
13.4.5. Business Strategy
13.5. McKesson Corporation
13.5.1. Overview
13.5.2. Financial Overview
13.5.3. Product Offerings
13.5.4. Developments
13.5.5. Business Strategy
13.6. IBM
13.6.1. Overview
13.6.2. Financial Overview
13.6.3. Product Offerings
13.6.4. Developments
13.6.5. Business Strategy
13.7. Medecision
13.7.1. Overview
13.7.2. Financial Overview
13.7.3. Product Offerings
13.7.4. Developments
13.7.5. Business Strategy
13.8. GetWellNetwork, Inc.
13.8.1. Overview
13.8.2. Financial Overview
13.8.3. Product Offerings
13.8.4. Developments
13.8.5. Business Strategy
13.9. MEDHOST
13.9.1. Overview
13.9.2. Financial Overview
13.9.3. Product Offerings
13.9.4. Developments
13.9.5. Business Strategy
13.10. Lincor
13.10.1. Overview
13.10.2. Financial Overview
13.10.3. Product Offerings
13.10.4. Developments
13.10.5. Business Strategy

14. Analyst Opinion
15. Annexure
15.1. Report Scope
15.2. Market Definitions
15.3. Research Methodology
15.3.1. Data Collation and In-house Estimation
15.3.2. Market Triangulation
15.3.3. Forecasting
15.4. Report Assumptions
15.5. Declarations
15.6. Stakeholders
15.7. Abbreviations

ページTOPに戻る



List of Tables/Graphs

Tables
TABLE 1. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 2. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HARDWARE, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR STANDALONE SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR INTEGRATED SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 8. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PREMISE MODE, 2021-2030 (USD BILLION)
TABLE 9. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CLOUD-BASED MODE, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 11. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HEALTH MANAGEMENT, 2021-2030 (USD BILLION)
TABLE 12. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HOME HEALTH MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 13. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SOCIAL, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 14. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR FINANCIAL HEALTH MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 15. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY THERAPEUTIC AREA, 2021-2030 (USD BILLION)
TABLE 16. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CHRONIC DISEASES, 2021-2030 (USD BILLION)
TABLE 17. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CARDIOVASCULAR DISEASES (CVD), BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 18. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR DIABETES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 19. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR OBESITY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 20. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CHRONIC DISEASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 21. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR WOMEN’S HEALTH, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 22. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR FITNESS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 23. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY FUNCTIONALITY, 2021-2030 (USD BILLION)
TABLE 24. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR INTRODUCTION, 2021-2030 (USD BILLION)
TABLE 25. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR E-PRESCRIBING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 26. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR VIRTUAL CONSULTATION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 27. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PATIENT/CLIENT SCHEDULING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 28. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR DOCUMENT MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 29. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 30. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PROVIDERS, 2021-2030 (USD BILLION)
TABLE 31. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PAYERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 32. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PATIENTS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 33. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR OTHER END USERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 34. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 35. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 36. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 37. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 38. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 39. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 40. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 41. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 42. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 43. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 44. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 46. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 47. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 48. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 49. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 50. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 51. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 52. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 53. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, END USE INDUSTRIES, 2021-2030 (USD BILLION)
TABLE 54. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 55. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 56. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 57. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 59. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 60. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 61. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 62. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 63. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 64. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 65. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 66. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 67. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 68. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 69. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 70. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 71. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 72. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 73. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 74. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 75. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 76. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 77. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 78. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 79. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 80. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 81. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 82. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 83. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 84. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 85. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 86. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 87. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 88. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 89. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 90. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 91. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 92. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 93. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 94. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 95. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 96. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 97. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 98. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 99. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 100. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 101. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 102. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 103. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 104. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 105. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 106. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 107. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 108. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 109. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 110. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 111. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 112. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 113. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 114. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 115. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 116. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 117. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 118. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 119. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 120. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 121. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 122. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 123. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 124. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION)
TABLE 125. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION)
TABLE 126. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 127. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 128. ALLSCRIPTS HEALTHCARE, LLC: FINANCIALS
TABLE 129. ALLSCRIPTS HEALTHCARE, LLC: PRODUCTS & SERVICES
TABLE 130. ALLSCRIPTS HEALTHCARE, LLC: RECENT DEVELOPMENTS
TABLE 131. ORION HEALTH: FINANCIALS
TABLE 132. ORION HEALTH: PRODUCTS & SERVICES
TABLE 133. ORION HEALTH: RECENT DEVELOPMENTS
TABLE 134. CERNER CORPORATION: FINANCIALS
TABLE 135. CERNER CORPORATION : PRODUCTS & SERVICES
TABLE 136. CERNER CORPORATION: RECENT DEVELOPMENTS
TABLE 137. MCKESSON CORPORATION: FINANCIALS
TABLE 138. MCKESSON CORPORATION: PRODUCTS & SERVICES
TABLE 139. MCKESSON CORPORATION: RECENT DEVELOPMENTS
TABLE 140. ATHENAHEALTH, INC.: FINANCIALS
TABLE 141. ATHENAHEALTH, INC.: PRODUCTS & SERVICES
TABLE 142. ATHENAHEALTH, INC.: RECENT DEVELOPMENTS
TABLE 143. IBM: FINANCIALS
TABLE 144. IBM: PRODUCTS & SERVICES
TABLE 145. IBM: RECENT DEVELOPMENTS
TABLE 146. MEDECISION: FINANCIALS
TABLE 147. MEDECISION: PRODUCTS & SERVICES
TABLE 148. MEDECISION: DEVELOPMENTS
TABLE 149. GETWELLNETWORK, INC.: FINANCIALS
TABLE 150. GETWELLNETWORK, INC.: PRODUCTS & SERVICES
TABLE 151. GETWELLNETWORK, INC.: RECENT DEVELOPMENTS
TABLE 152. MEDHOST: FINANCIALS
TABLE 153. MEDHOST: RODUCTS & SERVICES
TABLE 154. MEDHOST: RECENT DEVELOPMENTS
TABLE 155. LINCOR: FINANCIALS
TABLE 156. LINCOR: PRODUCTS & SERVICES
TABLE 157. LINCOR: RECENT DEVELOPMENTS

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

IHR Insights社の医療分野での最新刊レポート


よくあるご質問


IHR Insights社はどのような調査会社ですか?


IHR InsightsはICT、化学品、ヘルスケア、半導体など、世界の幅広い分野を対象に調査し、専門的な知識を基に市場調査報告書を出版しています。 主な調査分野 ◇ICT ◇化学品、材料、... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る